Optic Nerve Head Strain as Biomarker for Glaucoma
NCT: NCT06240312 · ACTIVE_NOT_RECRUITING
NCT IDNCT06240312
StatusACTIVE_NOT_RECRUITING
Start Date2024-07-01
Completion2028-01-31
SponsorJohns Hopkins University (OTHER)
First posted
Last updated
Brief Summary
The investigators will test the hypothesis that images of the optic nerve head taken a 2 different eye pressures will yield strain estimates that are predictive of the course of glaucoma.
Frequently Asked Questions
What is Optic Nerve Head Strain as Biomarker for Glaucoma?
Optic Nerve Head Strain as Biomarker for Glaucoma is a clinical trial registered under NCT06240312. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06240312?
The current status of NCT06240312 (Optic Nerve Head Strain as Biomarker for Glaucoma) is: ACTIVE_NOT_RECRUITING.
When did Optic Nerve Head Strain as Biomarker for Glaucoma start?
Optic Nerve Head Strain as Biomarker for Glaucoma started on 2024-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.